- Pfizer and BioNTech confirmed they will file with the FDA for emergency use authorization on Friday, after announcing the final Phase 3 coronavirus vaccine results a few days ago.
- The experimental drug proved to be highly effective in the final testing stage, and it had minimal side effects.
- The FDA will inspect the full data and should issue an Emergency Use Authorization quickly.
- Immunizations in the US could start within the next few weeks.
Pfizer and BioNTech shared the final efficacy results from their Phase 3 coronavirus vaccine trial a few days ago, revealing that the drug might be even better than what interim data showed. The two companies announced the vaccine is 95% effective and doesn’t have any severe side effects. They also said they would seek regulatory approval within days. It turns out they meant it, as Pfizer and BioNtech confirmed they plan to file with the FDA … Read the rest...